
### [MONDO:0019060](http://purl.obolibrary.org/obo/MONDO_0019060)
**Label:** rare bone tumor

**Subclasses:** [MONDO:0012817](http://purl.obolibrary.org/obo/MONDO_0012817) (Ewing sarcoma), [MONDO:0002629](http://purl.obolibrary.org/obo/MONDO_0002629) (bone osteosarcoma), [MONDO:0016388](http://purl.obolibrary.org/obo/MONDO_0016388) (bone sarcoma), [MONDO:0005164](http://purl.obolibrary.org/obo/MONDO_0005164) (fibrosarcoma (disease)), [MONDO:0005508](http://purl.obolibrary.org/obo/MONDO_0005508) (hereditary multiple exostoses), [MONDO:0018271](http://purl.obolibrary.org/obo/MONDO_0018271) (peripheral primitive neuroectodermal tumor), [MONDO:0007063](http://purl.obolibrary.org/obo/MONDO_0007063) (long bone adamantinoma), 

**Corr. equiv. classes:** [Orphanet:321](http://www.orpha.net/ORDO/Orphanet_321), [Orphanet:2030](http://www.orpha.net/ORDO/Orphanet_2030), [Orphanet:668](http://www.orpha.net/ORDO/Orphanet_668), [Orphanet:319](http://www.orpha.net/ORDO/Orphanet_319), [OMIM:612219](http://purl.obolibrary.org/obo/OMIM_612219), [Orphanet:223727](http://www.orpha.net/ORDO/Orphanet_223727), [OMIM:259500](http://purl.obolibrary.org/obo/OMIM_259500), [OMIM:102660](http://purl.obolibrary.org/obo/OMIM_102660), [Orphanet:370348](http://www.orpha.net/ORDO/Orphanet_370348), [Orphanet:55881](http://www.orpha.net/ORDO/Orphanet_55881), 

**Class expressions from DL-Learner:**

- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 40.00%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 39.02%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 36.65%
- [HP:0002659](http://purl.obolibrary.org/obo/HP_0002659) (Increased susceptibility to fractures) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) 33.90%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 33.37%
- Thing 33.36%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 33.36%
- [HP:0002659](http://purl.obolibrary.org/obo/HP_0002659) (Increased susceptibility to fractures) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 33.06%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 29.64%
- [HP:0002659](http://purl.obolibrary.org/obo/HP_0002659) (Increased susceptibility to fractures) 27.37%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 26.12%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 24.87%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 23.69%
- [HP:0011843](http://purl.obolibrary.org/obo/HP_0011843) (Abnormality of skeletal physiology) 22.40%
- [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) 21.89%


